236 related articles for article (PubMed ID: 28243079)
1. Can we predict the prognosis of COPD with a routine blood test?
Xiong W; Xu M; Zhao Y; Wu X; Pudasaini B; Liu JM
Int J Chron Obstruct Pulmon Dis; 2017; 12():615-625. PubMed ID: 28243079
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Monocyte-to-Lymphocyte Ratio (MLR) as Biomarkers in Diagnosis Evaluation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective, Observational Study.
Cai C; Zeng W; Wang H; Ren S
Int J Chron Obstruct Pulmon Dis; 2024; 19():933-943. PubMed ID: 38646605
[TBL] [Abstract][Full Text] [Related]
4. The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD.
Farah R; Ibrahim R; Nassar M; Najib D; Zivony Y; Eshel E
Panminerva Med; 2017 Sep; 59(3):203-209. PubMed ID: 28185443
[TBL] [Abstract][Full Text] [Related]
5. Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review.
Pascual-González Y; López-Sánchez M; Dorca J; Santos S
Int J Chron Obstruct Pulmon Dis; 2018; 13():3651-3662. PubMed ID: 30464448
[TBL] [Abstract][Full Text] [Related]
6. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.
Duman D; Aksoy E; Agca MC; Kocak ND; Ozmen I; Akturk UA; Gungor S; Tepetam FM; Eroglu SA; Oztas S; Karakurt Z
Int J Chron Obstruct Pulmon Dis; 2015; 10():2469-78. PubMed ID: 26648709
[TBL] [Abstract][Full Text] [Related]
7. Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker.
Acartürk Tunçay E; Karakurt Z; Aksoy E; Saltürk C; Gungor S; Ciftaslan N; Irmak İ; Yavuz D; Ocakli B; Adıgüzel N
Int J Chron Obstruct Pulmon Dis; 2017; 12():3361-3370. PubMed ID: 29200843
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of neutrophil to lymphocyte ratio in patients with chronic obstructive pulmonary disease: a prospective observational study.
Lee SJ; Lee HR; Lee TW; Ju S; Lim S; Go SI; You JW; Cho YJ; Lee GW; Jeong YY; Kim HC; Lee JD
Korean J Intern Med; 2016 Sep; 31(5):891-8. PubMed ID: 27017385
[TBL] [Abstract][Full Text] [Related]
9. Blood biomarkers as predictors of long-term mortality in COPD.
Mendy A; Forno E; Niyonsenga T; Gasana J
Clin Respir J; 2018 May; 12(5):1891-1899. PubMed ID: 29227024
[TBL] [Abstract][Full Text] [Related]
10. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study.
Günay E; Sarınç Ulaşlı S; Akar O; Ahsen A; Günay S; Koyuncu T; Unlü M
Inflammation; 2014 Apr; 37(2):374-80. PubMed ID: 24078279
[TBL] [Abstract][Full Text] [Related]
12. Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation.
Wu Y; Qin J; He J; Shen Y; Wang H; Li Y; Zeng Q; Dong J; An Y; Xiong S; Feng M; Wen F
Int J Chron Obstruct Pulmon Dis; 2020; 15():397-407. PubMed ID: 32158205
[TBL] [Abstract][Full Text] [Related]
13. The Neutrophil to Lymphocyte Ratio Is Related to Disease Severity and Exacerbation in Patients with Chronic Obstructive Pulmonary Disease.
Furutate R; Ishii T; Motegi T; Hattori K; Kusunoki Y; Gemma A; Kida K
Intern Med; 2016; 55(3):223-9. PubMed ID: 26831014
[TBL] [Abstract][Full Text] [Related]
14. Circulating syndecan-1 as a novel biomarker relates to lung function, systemic inflammation, and exacerbation in COPD.
Li D; Wu Y; Guo S; Qin J; Feng M; An Y; Zhang J; Li Y; Xiong S; Zhou H; Zeng Q; Chen L; Wen F
Int J Chron Obstruct Pulmon Dis; 2019; 14():1933-1941. PubMed ID: 31695352
[TBL] [Abstract][Full Text] [Related]
15. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.
Lacoma A; Prat C; Andreo F; Lores L; Ruiz-Manzano J; Ausina V; Domínguez J
Int J Chron Obstruct Pulmon Dis; 2011; 6():157-69. PubMed ID: 21468168
[TBL] [Abstract][Full Text] [Related]
16. Predictive Value of Combining Inflammatory Biomarkers and Rapid Decline of FEV
Wang Y; Liao J; Zhong Y; Zhang C; Li X; Wang G
Int J Chron Obstruct Pulmon Dis; 2019; 14():2825-2833. PubMed ID: 31824147
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients.
Sakurai K; Chubachi S; Irie H; Tsutsumi A; Kameyama N; Kamatani T; Koh H; Terashima T; Nakamura H; Asano K; Betsuyaku T
BMC Pulm Med; 2018 May; 18(1):65. PubMed ID: 29720140
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of platelet and neutrophil to lymphocyte ratio in COPD patients.
El-Gazzar AG; Kamel MH; Elbahnasy OKM; El-Naggar ME
Expert Rev Respir Med; 2020 Jan; 14(1):111-116. PubMed ID: 31577911
[No Abstract] [Full Text] [Related]
19. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.
Yao C; Liu X; Tang Z
Int J Chron Obstruct Pulmon Dis; 2017; 12():2285-2290. PubMed ID: 28814856
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein levels in stable COPD patients: a case-control study.
Silva DR; Gazzana MB; Knorst MM
Int J Chron Obstruct Pulmon Dis; 2015; 10():1719-25. PubMed ID: 26357470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]